8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

Insulet ($PODD) announced Q4 & full-year 2025 financial results on Feb 18, 2026 covering the period ended…

Filed with the SEC on February 18, 2026 · Summarized by InvestorsBot

Insulet ($PODD) announced Q4 & full-year 2025 financial results on Feb 18, 2026 covering the period ended Dec 31, 2025. Press release is furnished as Exhibit 99.1 to the 8‑K — see the release for full metrics. 📣📄 #PODD #Earnings #DiabetesTech

Important: the Feb 18, 2026 disclosure (Ex. 99.1) is “furnished, not filed” — not subject to Section 18 liabilities and not automatically incorporated by reference into other SEC filings. ⚖️ℹ️ $PODD #SEC #Investing

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from INSULET CORP

Insulet ($PODD) filed a Form 8‑K on Mar 12, 2026 furnishing a press release (Exhibit 99.1) dated Mar 12, 2026.

8-K · March 12, 2026

Mar 12, 2026: Insulet ($PODD) says voluntary medical-device correction; expects up to $40M of costs, all…

8-K · March 12, 2026

Insulet ($PODD) on Feb 27, 2026 entered a severance agreement with former CFO Ana M.

8-K · March 4, 2026

Insulet ($PODD) filed an 8‑K on Feb 18, 2026 furnishing a press release as Exhibit 99.1.

8-K · February 18, 2026

On Feb 13, 2026 Insulet's Board approved a $350M increase to the prior $125M share repurchase…

8-K · February 18, 2026

Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc.

8-K · February 3, 2026